Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With Sarcoidosis

NCT02039687 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuropathy of Sarcoidosis

Interventions

DRUG: ARA 290
OTHER: Placebo

Sponsor

Araim Pharmaceuticals, Inc.